AJP - Renal Watch the video to learn how APS reaches out to developing nations.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Renal Physiol 297: F639-F645, 2009. First published July 8, 2009; doi:10.1152/ajprenal.00188.2009
0363-6127/09 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
297/3/F639    most recent
00188.2009v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Google Scholar
Right arrow Articles by Gil-Peña, H.
Right arrow Articles by Santos, F.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gil-Peña, H.
Right arrow Articles by Santos, F.

Alterations of growth plate and abnormal insulin-like growth factor I metabolism in growth-retarded hypokalemic rats: effect of growth hormone treatment

Helena Gil-Peña,1 Enrique Garcia-Lopez,2 Oscar Alvarez-Garcia,1 Vanessa Loredo,1 Eduardo Carbajo-Perez,3 Flor A. Ordoñez,1 Julian Rodriguez-Suarez,1 and Fernando Santos1,3

1Hospital Universitario Central de Asturias, 2Hospital Álvarez Buylla, and 3Universidad de Oviedo, Asturias, Spain

Submitted 1 April 2009 ; accepted in final form 1 July 2009

Hypokalemic tubular disorders may lead to growth retardation which is resistant to growth hormone (GH) treatment. The mechanism of these alterations is unknown. Weaning female rats were grouped (n = 10) in control, potassium-depleted (KD), KD treated with intraperitoneal GH at 3.3 mg·kg–1·day–1 during the last week (KDGH), and control pair-fed with KD (CPF). After 2 wk, KD rats were growth retarded compared with CPF rats, the osseous front advance (±SD) being 67.07 ± 10.44 and 81.56 ± 12.70 µm/day, respectively. GH treatment did not accelerate growth rate. The tibial growth plate of KD rats had marked morphological alterations: lower heights of growth cartilage (228.26 ± 23.58 µm), hypertrophic zone (123.68 ± 13.49 µm), and terminal chondrocytes (20.8 ± 2.39 µm) than normokalemic CPF (264.21 ± 21.77, 153.18 ± 15.80, and 24.21 ± 5.86 µm). GH administration normalized these changes except for the distal chondrocyte height. Quantitative PCR of insulin-like growth factor I (IGF-I), IGF-I receptor, and GH receptor genes in KD growth plates showed downregulation of IGF-I and upregulation of IGF-I receptor mRNAs, without changes in their distribution as analyzed by immunohistochemistry and in situ hybridization. GH did not further modify IGF-I mRNA expression. KD rats had normal hepatic IGF-I mRNA levels and low serum IGF-I values. GH increased liver IGF-I mRNA, but circulating IGF-I levels remained reduced. This study discloses the structural and molecular alterations induced by potassium depletion on the growth plate and shows that the lack of response to GH administration is associated with persistence of the disturbed process of chondrocyte hypertrophy and depressed mRNA expression of local IGF-I in the growth plate.

tubulopathies; chondrocyte; cartilage



Address for reprint requests and other correspondence: F. Santos, Pediatria, Facultad de Medicina, C/Julian Claveria 6, 33006 Oviedo, Asturias, Spain (e-mail: fsantos{at}uniovi.es)







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2009 by the American Physiological Society.